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ABSTRACT 
Adverse increases in adiposity and reductions in lean soft tissue (LST) are age related changes in 
body composition and are linked to an increased risk for metabolic disease and declines in 
physical function in older women. Higher protein intake under caloric reduced conditions 
eliciting weight loss may augment fat mass (FM) loss, which can reduce metabolic disease risk; 
and attenuate LST loss, which may benefit physical function. This study assessed effects of 6 mo 
weight loss supplemented with powdered protein or placebo on body composition, metabolic 
disease risk factors and physical function in older obese women. Twenty-six women (64.7±5.8 
yrs, BMI 32.5±4.1 kg/m
2
) were prescribed an energy-restricted diet (1400 kcal/d) and randomly 
assigned to PRO (n=13; 0.8 g/kg/d of dietary protein plus 45g/d of whey protein isolate 
supplement, resulting in ~30% of energy intake from protein, 40% of energy from carbohydrate 
and 30% of energy from fat) or CARB (n=13; 0.8 g/kg/d protein plus 50 g/d of an isocaloric 
maltodextrin supplement, resulting in ~18% of energy from protein, 52% of energy from 
carbohydrate and 30% of energy from fat) supplementation. Healthy eating based on the USDA 
My Pyramid diet education classes were taught by a registered dietitian every 2 weeks. 
Supervised exercise classes, consisting of flexibility and low to moderate intensity walking on an 
indoor track, were provided 5 d/wk, of which participants were required to attend 2-3 exercise 
classes/wk. The main outcome measures included the following: whole body FM and LST with 
DXA; thigh muscle volume, subcutaneous adipose tissue (SAT), intermuscular adipose tissue 
(IMAT) with MRI; glucose, insulin, C-reactive protein (CRP) and interleukin-6 (IL-6) from 
fasting blood samples; knee extension and flexion strength with isokinetic and isometric 
dynamometry; balance using the Star Excursion Balance Test (SEBT); and physical performance 
assessed from up and go, chair stand, stair climb and transfer tests. Three-day weighed food 
diaries were collected at baseline, month 3 and post-intervention, and 7-day pedometer step 
counts were measured monthly. PRO trended towards greater weight loss (-8.0±6.2%, -
4.1±3.6%; p=0.059), had greater reductions in abdominal FM (-14.8±15.0%, -4.1±8.1%; 
p=0.037) but no significant differences in losses of FM (-15.4±17.8%, -6.1±5.4%; p=0.091), 
greater reductions in SAT (-18.8±13.5, -7.9±6.9; p=0.024) and IMAT (-9.2±9.4, -1.0±7.7; 
p=0.028) but no difference in IMAT relative to muscle volume (4.7±5.8, 4.3±8.6; p=0.883) 
compared to CARB, respectively. No differences were seen in LST changes (-4.0±4.9%, -
2.0±4.1%; p=0.414), but PRO had a greater improvement in weight to leg LST ratio (-4.6±3.6, -
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1.8±2.6; p=0.033), greater reductions in absolute thigh muscle volume (-5.0±3.4, -0.8±3.9; 
p=0.010) and greater gains in relative thigh muscle volume (10.3±8.8%, 4.5±3.4; p=0.049) 
compared to CARB. Groups did not differ in changes in metabolic disease risk factors, knee 
strength, balance or physical performance measures. Change in SAT volume was an independent 
predictor of % change in CRP explaining 30% of the variance (p=0.021), and change in 
abdominal fat mass showed a trend towards independently predicting % change in CRP 
(p=0.057). Changes in weight to leg LST ratio predicted changes in up and go (adjusted 
r
2
=0.189, p=0.02); whereas whole body %LST predicted changes in balance (adjusted r
2
=0.179, 
p=0.04). Higher protein weight loss diet in older women contributes to more weight loss and 
optimal changes in body composition compared to a greater carbohydrate regimen. Protein 
intake does not appear to directly impact changes in metabolic risk factors or physical function; 
however, changes in abdominal fat and SAT reduce systemic inflammation, and preservation of 
LST with weight reduction improves balance and physical performance.  
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CHAPTER 1 
Introduction 
 
1.1 Significance 
Obesity has reached epidemic proportions in the United States. NHANES II and III data 
show that the prevalence of overweight and obesity
 
increase with age (1). With approximately 
37% and 32% of women 60 years and older being classified as overweight and obese, 
respectively, combined with the known associations of excess adiposity to adverse health risk 
obesity in this cohort is a major public health concern (2). According to 2000 U.S. census data, 
approximately 47 million Americans, or 40% of the adult population, meet the diagnosis criteria 
for metabolic syndrome (3), with a greater prevalence in women than in men, and higher 
cardiovascular disease mortality rates in women (4).  
 Several factors place women at a greater risk for metabolic disease. Longitudinal data 
from the Health ABC Study shows that associations between abdominal obesity, dyslipidemia 
and high blood pressure with metabolic syndrome are stronger in older women than men (5). 
Postmenopausal shifts in hormone levels are associated with women  increasing abdominal 
obesity (3), a strong independent predictor of metabolic disease (6). Abdominal fat is associated 
with low-grade inflammation, measured by increased circulating levels of C-reactive protein 
(CRP), a key characteristic of metabolic disease and an independent predictor of future 
cardiovascular events (7). Novel adipose tissue depots, such as subcutaneous adipose tissue 
(SAT), measured using magnetic resonance imaging (MRI), have been associated with glucose 
intolerance (8) and insulin resistance (9); and intermuscular adipose tissue (IMAT) with type 2 
diabetes (10) and metabolic syndrome (11). Higher levels of systemic inflammatory markers are 
found in women than in age-matched men (12-16), further exacerbating gender differences in 
health risks.  
 Aging is not only associated with an increase in fat mass, but also a decrease in skeletal 
muscle mass (17). Moreover, obese older adults tend to have lower skeletal muscle mass relative 
to body weight (18-20), and poor muscle quality (21-23) relative to non-obese counterparts. 
These age-related changes in body composition can result in decreased muscle strength (24), 
mobility limitations (25), an inability to perform daily activities (19), and greater risk for 
physical disability (18, 26). Gender inequity exists with regard to body composition and physical 
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function as older women have greater adiposity (27-28), less lean mass (27-28), lower muscle 
quality (27, 29), worse balance and gait function than men of similar age (30-32), as well as a 
greater prevalence of falling (33-34) and a higher risk of physical disability (35-36). 
 Because weight loss in the elderly may result in loss of proportionally more fat free mass 
(FFM) than fat mass (28), the type of weight loss therapy (i.e. diet vs. exercise, or macronutrient 
content of diet) and magnitude and rate of weight loss are important factors impacting changes in 
body composition. Emerging data from the Health ABC Study indicate that older adults 
consuming greater amounts of protein are less likely to lose lean mass over time (37). Increasing 
protein intake as part of a low-calorie diet has been shown to promote more total weight and fat 
mass loss (38-41) while also attenuating loss of muscle relative to changes in adiposity (41-44) 
compared to an isocaloric diet with a conventional macronutrient composition (i.e. higher 
carbohydrate). The American Society for Nutrition and NAASO, The Obesity Society, 
specifically recommend weight loss therapies that maximize fat mass loss and minimize skeletal 
muscle loss in order to improve metabolic abnormalities and maintain physical function and 
independence in the elderly (17, 21). In this context, the overarching goal of this study was to 
assess the relative effects of weight loss diets varying in macronutrient content on a) whole body, 
regional and ectopic fat or adipose tissue and b) lean mass and muscle volume in overweight 
older women.   
 
1.2 Specific Aims 
Primary Aim 1: To assess the effect of a higher protein, lower carbohydrate (PRO) intake during 
energy restriction on 1) body fat depots, particularly thigh SAT and IMAT, and 2) indicators of 
metabolic disease risk, compared with an isocaloric conventional higher carbohydrate, lower 
protein (CARB) intake in older women.  
 
Secondary Aim 1: To examine the relative association of changes in the various fat or adipose 
tissue depots with changes in markers of metabolic disease risk. 
 
We hypothesized that a PRO weight loss diet would result in greater reductions in fat mass and 
adipose tissue compared with an isocaloric CARB diet, and that this would be related to 
beneficial effects on metabolic disease risk. 
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Primary Aim 2: To assess the effect of a PRO weight loss diet on lean soft tissue, muscle volume 
and physical function, compared with an isocaloric conventional higher carbohydrate, lower 
protein weight loss diet CARB.  
 
Secondary Aim 2: To identify measures of muscle quality which best predict changes in physical 
function, characterized by strength, balance and physical performance.  
 
We hypothesized that a PRO weight loss diet would result in attenuation of lean mass loss 
compared with an isocaloric CARB diet, and that these changes may convey beneficial effects on 
physical function.  
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Figure 1. Hypothesized interrelations among protein intake and primary outcomes in this study. 
Bold arrows represent primary and secondary aims of this study and dotted arrows represent 
other possible interactions.   
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CHAPTER 2 
Literature Review 
 
 Obesity has reached epidemic proportions in the United States. NHANES II and III data 
show that the prevalence of overweight [defined as body mass index (BMI)  25 kg/m2] and 
obesity (defined as BMI  30 kg/m2) increase with age, and furthermore, the prevalence of 
obesity has increased in older adults over the last two decades (1). More recent NHANES III 
data indicate, however, that although the prevalence of overweight and obesity appears to be 
leveling off in men over the age of 60, prevalence in women of the same age may be slightly 
decreasing (2). Nevertheless, with approximately 37% and 32% of elderly women classified as 
overweight and obese, respectively, this is a major health concern (2).  
 Based on NHANES III data, the prevalence of sarcopenia, defined by skeletal muscle 
mass relative to body weight or height, increases with age in both men and women, but more so 
in women (3). Sarcopenia is not simply an issue of thin frailty; rather, severe sarcopenia, defined 
by a sarcopenia index below two standard deviations of young adult values, is also found in 
obese elderly men and women (3). Even if muscle mass is maintained in obese elderly, muscle 
quality becomes increasingly compromised with aging, indicated by lower muscle attenuation 
(decreased muscle density) and or adipose infiltration of the muscle, measured using computed 
tomography (4).  
 This chapter summarizes the current research on health implications of age-related 
changes in body composition, including 1) the association between adiposity and risk for 
metabolic disease, and 2) the association between decreased muscle mass and risk for physical 
limitations. Lastly, weight loss regimens aimed at improving these health risks are addressed, 
with an emphasis on dietary interventions that incorporate higher protein, lower carbohydrate 
(PRO) intake compared to a conventional higher carbohydrate, lower protein (CARB) diet.  
 
2.1 Adiposity Associated with Aging Increases Risk for Metabolic Disease 
 Metabolic syndrome comprised of a cluster of health abnormalities, including central 
obesity, dyslipidemia, hypertension, and impaired fasting glucose, all of which are also risk 
factors for other metabolic diseases such as type 2 diabetes and cardiovascular disease. The 
prevalence for obesity and metabolic syndrome, and thus the risk for other disease states, 
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increases with age (5). In an aged population, comparing men and women, health inequities exist 
with older women having greater adiposity (6), and greater subcutaneous thigh adipose tissue 
than men of the same age (4, 7). Despite equal levels of thigh IMAT, muscle quality, measured 
by muscle attenuation, is lower (i.e. greater intramyocellular lipid accumulation) in older women 
than in older men (4, 7). According to 2000 U.S. census data, approximately 47 million 
Americans, or 40% of the adult population, meet the diagnosis criteria for metabolic syndrome 
(5), with a greater prevalence in women than in men (8). Furthermore, cardiovascular disease 
mortality rates are higher in women than in men (9).  
 Several factors place women at a greater risk for metabolic disease. Firstly, women tend 
to present with greater insulin resistance and glucose intolerance measured by oral glucose 
tolerance test (5). Secondly, longitudinal data from the Health ABC Study shows that 
associations between abdominal obesity, dyslipidemia and high blood pressure with metabolic 
syndrome are stronger in older women than men (8). Postmenopausal shifts in hormone levels 
lead to women often developing abdominal obesity (5), a stronger independent predictor of 
metabolic disease risk than BMI (10). In fact, data from the Baltimore Longitudinal Study of 
Aging suggests that every 5 cm increase in waist circumference is associated with a 70% higher 
risk for developing metabolic syndrome over time (11). 
 Adipocyte dysfunction in visceral adiposity plays a major role in the development of 
metabolic disease. Although inflammatory markers are not standard in diagnosing metabolic 
syndrome, low-grade inflammation, measured by increased circulating levels of C-reactive 
protein (CRP), is a key characteristic and is known to be an independent predictor of future 
cardiovascular events (12). The pathophysiology of metabolic syndrome seems to be attributable 
to visceral adipose, a metabolically active tissue which secretes various endocrine and pro-
inflammatory products, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), leptin and 
adiponectin, starting a cascade of events leading to insulin resistance (13). This in turn impairs 
the function of organs, such as the muscle and liver, in maintaining glucose and lipid 
homeostasis, and leads to lipid deposition in ectopic tissues (13).  
 Aging is associated with increased levels of several inflammatory cytokines including IL-
6 and CRP (14). Other factors that contribute to the low-grade inflammation typically found in 
older adults, in addition to the aging immune system and possible sub-clinical infections, are 
increased adipose tissue and decreased muscle mass (14), both of which are age-related changes 
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in body composition. In addition, physical activity, which is generally low in the elderly 
population (15), is inversely associated with CRP levels in the elderly (16), which may be partly 
related to the link between habitual physical activity and adiposity and decreased muscle mass. 
Higher levels of systemic inflammatory markers are found in women than in age-matched men 
(17-21), further exacerbating gender differences in health risks. Moreover, the association 
between fat mass and inflammation is stronger in older women than men of similar age (22), 
suggesting that the greater adiposity generally found in women places them at even higher risk 
for inflammation.    
 Interestingly, recent findings from the Health ABC Study link obesity and metabolic 
syndrome with incident mobility limitations (8, 23). Both obesity and metabolic syndrome 
independently predict development of mobility limitations in older women (23). Furthermore, 
even after adjusting for whole body obesity, abdominal obesity remained independently 
associated with incident mobility limitations (8) and elevated inflammatory markers IL-6, TNF-α 
and CRP, partly explained the association between obesity, metabolic syndrome and mobility 
limitations (23).  
 
2.2 Physical Function Changes with Aging, Adiposity and Sarcopenia 
 According to the Behavioral Risk Factor Surveillance System (BRFSS), almost 30% of 
the population above 65 years of age in the United States are limited by a physical disability 
(24). Functional limitations can reduce vitality, increase physical pain and have a significant 
impact on quality of life in the elderly (25). Lower physical function, measured subjectively by 
reported difficulties performing Activities of Daily Living (ADL) and objectively by physical 
performance tests, is often associated with age-related changes in body composition, such as 
increased body fatness and a lower sarcopenic index (3, 26). In addition, low muscle strength and 
low muscle attenuation are associated with a higher risk for mobility limitations in walking and 
climbing steps (27).  
 Due to gender differences in age-related changes in body composition, women are at a 
greater risk for developing mobility limitations compared to men. The prevalence of sarcopenia 
according to NHANES III data is greater in women than men above 60 years of age; 
approximately 70% in older women compared with 50% in older men (3). Although the 
magnitude of associations between muscle quality and muscle strength appear to be similar in 
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men and women (4) and men lose proportionally more strength due to aging (28), men are 
nevertheless more fatigue resistant in strength tests (7), have greater leg strength and force 
production than women of the same age (4, 7, 29). Since both body composition and functional 
outcomes are less favorable in older women than men, it is not surprising that the prevalence of 
physical disability and functional impairment in older women is greater than the prevalence in 
men of similar age, with the differences being even greater between sarcopenic older women and 
men (3). 
 Components of physical function include muscle strength, balance and physical 
performance (i.e. measures of walking, gait, timed tasks), and there is a wide variety of studies in 
the literature, describing associations between different measures of body composition and 
components of physical function. Briefly, in cross-sectional studies assessing associations 
between body composition and measures of physical function, women with obese sarcopenia 
have a 3.8 times greater risk for functional limitation than women with greater levels of skeletal 
muscle mass relative to weight (26). Furthermore, lower relative whole body skeletal muscle 
mass is reported to be associated with lower leg strength (26) and poor physical performance (3). 
In healthy older women skeletal muscle mass and fat mass relative to body weight are strong 
predictors of physical performance measured by walking, gait and balance (30). In addition, 
thigh muscle attenuation (level of fat infiltration of the muscle, i.e. a parameter for muscle 
quality) has been associated with self-reported mobility limitations (27), therefore it may also be 
important to measure changes within the muscle. 
 
2.3 Weight Loss Effects on Metabolic Disease Risk and Physical Function 
 The effects of weight loss on health risks in older women are somewhat controversial. 
Obesity in older adults is associated with several health risks, including type 2 diabetes mellitus, 
cardiovascular disease, cancer and arthritis, and weight loss of 10% is recommended for 
improving mortality risk (31). However, weight loss of this magnitude can have negative 
consequences in older women. Firstly, some population studies show that weight loss in the 
elderly is associated with increased mortality, however, this is often involuntary and due to 
disease (32). Importantly, weight loss in older women decreases bone density and increases risk 
for osteoporosis (33). Furthermore, weight loss results in not only loss of fat mass, but also FFM 
(6, 34-35), which in older women may impact physical function. Although intuitive, the 
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interrelations between changes in fat and lean mass, muscle strength and physical performance 
are understudied in this population.   
 Moderate weight loss of 5-10% of initial body weight over 3-6 months via an energy 
restricted diet generally has a significant impact on body composition in older women: whole 
body fat mass, subcutaneous fat, FFM, and appendicular lean tissue decrease (34-37). Muscle 
quality also improves with weight loss. Muscle biopsy samples from obese patients who had 
undergone weight loss therapy show that muscle fiber lipid content is increased in obesity and 
decreases as a result of weight loss (38), although this has not been shown in all studies (39). 
Furthermore, IMAT and low-density muscle area decreases without a change in total muscle 
area, in moderate weight loss in obese postmenopausal women (35). 
 Findings on changes in body composition vary when weight loss is induced with exercise 
in addition to dietary energy restriction. A decrease in fat depots (whole body fat mass, thigh 
subcutaneous and IMAT areas) is consistent throughout studies (36, 40). As for muscle mass, 
some studies show a decrease in FFM or lean mass (37), whereas it appears that exercise can 
help preserve FFM (40) and skeletal muscle (36-37) in other studies. Also, it is not clear whether 
exercise combined with dietary energy restriction decreases muscle fiber lipid content (39).  
 Major prospective lifestyle intervention trials have shown that weight loss of 7% of initial 
weight through diet, exercise or a combination of both can decrease the risk for type 2 diabetes 
by 58%, or even up to 80% if exercise levels are maintained at 4 h/wk (41). Changes in 
abdominal obesity, in particular, can have a major impact on metabolic disease risk factors. 
Decreasing visceral adipose by 25% within 12 weeks with a very low calorie diet can improve 
insulin sensitivity by 33% (42), although it appears moderate weight loss is preferential for 
sustained benefits from reductions in abdominal fat (43). Weight loss is a key component of 
reducing inflammation, as it is well established that changes in weight and fat mass resulting 
from an energy-restricted diet are associated with proportional changes in CRP levels (44-45), 
particularly in obese postmenopausal women (46). 
 Population studies show that overweight and obesity in older women are associated with 
poor physical function (47-48). Although a limited number of studies have been conducted in 
older adults assessing the effect of weight loss on physical function, weight loss is shown to help 
improve physical function and quality of life in the elderly (25). A moderate weight loss regimen 
that incorporated both energy restriction and exercise resulted in a decrease in fat mass and no 
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change in FFM, and improved measures of physical performance such as balance, gait, walking 
speed, climbing stairs and knee strength in healthy obese elderly (49) and in obese elderly with 
knee osteoarthritis (50-52). Limited data in obese elderly with knee osteoarthritis undergoing 
weight loss therapy indicate that changes in fat and lean mass, assessed with dual energy X-ray 
absorptiometry, are inversely associated with knee strength (52).  
 Controversy in recommendations for weight loss in older populations is in regards to the 
trade-off between improved health outcomes from decreased mortality and metabolic disease 
risk on the one hand, and poor physical independence from decreased muscle mass leading to 
reduced strength on the other. Additional research is clearly needed on weight loss regimens that 
may promote loss of fat while preserving FFM, so that improvements may be seen in both a 
reduced risk for metabolic disease and improvements in physical function.   
 
2.4 Macronutrient Composition of Weight Loss Diets 
 Determining the optimal macronutrient composition of a weight loss diet is important 
because this may have favorable effects on body composition, as weight loss is often 
accompanied by loss of not only fat mass but also lean mass, which could in turn impact risk of 
reduced physical function. The most beneficial macronutrient composition of an energy 
restricted weight loss diet is still debated.  
 PRO weight loss diets appear to result in greater weight loss compared with a CARB diet 
(53-56). Also, it appears that more participants are successful in reaching a 10% weight loss goal 
when on a PRO weight loss diet (57). Furthermore, longer-term PRO weight loss diets are shown 
to predict weight loss in women (58). Mechanisms for improved weight loss from a PRO diet are 
likely due to a greater satiety associated with protein intake, and an increased thermogenic effect 
of food (59-60). 
 Findings from a meta-analysis on the macronutrient composition of energy-restricted 
diets indicate that protein intake of >1.05g/kg body weight is associated with greater retention of 
FFM than diets with protein intake below this level, but protein intake at this level is not 
associated with greater loss of fat mass (61). Alternatively, lower carbohydrate intake (41% of 
energy intake) is associated with greater FFM and fat mass loss than higher carbohydrate diets 
(61). In addition, more recent findings not included in this meta-analysis show no effects of the 
dietary macronutrient composition on weight loss, or changes in fat and lean mass (62-65).  
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 Recent findings from the Health ABC prospective cohort study report an association 
between protein intake and changes in lean mass over 3 years: elderly men and women with a 
protein intake 1.2g/kg body weight lost less lean and appendicular lean mass that those with 
0.8g/kg (66). This is supported by data from our laboratory showing that a PRO weight loss diet 
(1.6g protein/kg body weight) is more effective in decreasing fat mass while preserving lean 
mass in middle-aged women than a CARB (56). Furthermore, the PRO weight loss diet 
combined with exercise had an additive effect on body composition, decreasing relatively more 
body fat while preserving more lean mass than a CARB diet combined with exercise or the PRO 
diet alone (56).  
 Studies examining effects of a PRO weight loss diet have generally found improved 
metabolic profile, including fasting glucose, fasting insulin, total cholesterol, LDL cholesterol, 
HDL cholesterol, triglycerides and free fatty acids, following weight loss but with no significant 
effect of the PRO dietary treatment (53, 55, 67-69). Most studies have found that protein content 
of a weight loss diet does not appear to be a significant factor in decreasing inflammation, as 
both PRO and CARB weight loss diets appear to decrease CRP levels by a similar magnitude 
(53, 55, 63). However, CRP was found to be associated with changes in FM following a high 
protein weight loss diet (70).  
 Factors that may influence the outcomes and explain differences in findings between 
studies include different protein sources used to increase intake (food items vs. protein 
supplementation with powder) and how protein intake was divided over the course of the day 
(one bolus/day vs. several) which may impact bioavailability as well as satiety, in addition to 
duration of the study and adherence to the weight loss diet. Also, findings may vary by gender, 
as lean mass may be preserved more effectively during weight loss in women with PRO 
regimens (71). Additional studies are needed to assess the effects of a PRO weight loss diet on 
body composition. In addition, the effect of a PRO diet on adipose tissue infiltration of the 
muscle measured by MRI is unknown. Furthermore, to our knowledge, no studies have assessed 
associations between changes in body composition following a PRO weight loss diet and 
physical function in the older women.  
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CHAPTER 3 
The Effects of a Higher Protein Intake During Energy Restriction on 
Changes in Fat Mass, Adipose Tissue and Metabolic Disease Risk in 
Postmenopausal Women  
 
3.1 Introduction 
 Obesity has reached epidemic proportions in the United States, with 69% of women aged 
60 and older being classified as overweight, and 32% as obese (1). Adiposity is known to 
increase risk for metabolic disease, such as cardiovascular disease, metabolic syndrome and type 
2 diabetes (2). Weight loss of 10% is recommended for improving mortality (3); however, it 
remains somewhat controversial in the older population, as weight loss results in loss of not only 
fat mass but also bone (4) and muscle mass (5-7). Compared to their male counterparts, older 
women are at an increased risk for obesity (1), osteoporosis and fractures (8), and physical 
disability (9). Therefore, it is important to determine the most effective weight loss regimens to 
elicit optimal changes in body composition to decrease obesity related metabolic disease risk in 
older adults, especially females.  
 In addition to increased absolute and relative whole body fat associated with aging, obese 
and older adults appear to have an increased accumulation of adipose infiltration in the muscle 
(10-11). Novel adipose tissue depots, such as subcutaneous adipose tissue (SAT), measured 
using magnetic resonance imaging (MRI), has been associated with glucose intolerance (12) and 
insulin resistance (13); and intermuscular adipose tissue (IMAT) with type 2 diabetes (14) and 
metabolic syndrome (15).  
 Regarding macronutrient content of the weight loss diet, increasing protein intake as part 
of a low-calorie diet has been shown to promote more total weight and fat mass loss (16-19) 
compared to an isocaloric diet with a conventional macronutrient composition (i.e. higher 
carbohydrate). However, evidence is equivocal whether there is a beneficial effect of higher 
protein intake during weight loss on measures of risk for metabolic disease (16-18, 20), 
especially independent of changes in adiposity. Moreover, to date, no studies have assessed 
changes in thigh SAT and IMAT resulting from energy restricted diets varying in macronutrient 
content and the potential impact on risk for metabolic disease in older females.   
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  In this context, the aim of this study was to assess the effects of a higher protein, lower 
carbohydrate (PRO) intake during energy restriction on 1) fat/adipose depots, particularly thigh 
SAT and IMAT, and 2) indicators of metabolic disease risk, compared with a conventional 
higher carbohydrate, lower protein weight loss diet (CARB) in older females. The secondary aim 
was to examine whether changes in markers of metabolic disease were mediated by changes in 
fat mass or adipose tissue. We hypothesized that a PRO weight loss diet will result in greater loss 
of fat mass and adipose tissue compared with an isocaloric CARB diet, and that this would be 
related to beneficial effects on metabolic disease risk.  
 
3.2 Methods 
 Study design and participants. Thirty-one healthy, overweight or obese postmenopausal 
women (mean age±SD: 65.2±4.6 yrs; 29 Caucasian, 1 African American, 1 Latina) were 
recruited from the community for a 6 month double-blind, randomized weight loss trial. 
Exclusion criteria were as follows: BMI <28 kg/m
2
; >136 kg weight; major weight change 
defined as >2.3 kg change in the prior 6 mo; postmenopausal <5 yrs; regular physical activity >1 
h/wk or >2 sessions/wk in the prior 6 mo; regular smoking within the prior 10 yrs; history of 
conditions that impact the primary outcomes such as cancer, cardiovascular disease, type 2 
diabetes, renal disease, musculoskeletal or neuromuscular impairments; and use of medications 
that may impact bone metabolism, such as hormone replacement therapy or osteoporosis drugs, 
within the prior 2 years. Health history was obtained with a questionnaire, which included items 
on medications, use of non-steroidal anti-inflammatory drugs, supplements and history of 
conditions other than ones listed as exclusion criteria (e.g. arthritis). Participants were screened 
with standard blood tests (comprehensive metabolic panel and complete blood count). All 
participants were required to provide personal physician clearance prior to enrollment. All 
participants signed a consent form approved by the University of Illinois Institutional Review 
Board upon enrollment in the study. Participants were blocked on age and BMI with subsequent 
random assignment to either PRO or CARB treatment. Researchers and participants were 
blinded to which treatment, PRO or CARB, the participants received. 
 Dietary treatment. Participants were provided with a supplement: the PRO group 
received 50 g/d of 90% whey protein isolate, and the CARB group received 50g/d of 
maltodextrin. Participants were asked to ingest half (25g) of the supplement in the morning with 
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breakfast and the other half in the afternoon or evening. The PRO diet prescribed was designed 
to provide 0.8 g/kg/d of dietary protein with an additional 45g/d of protein from the supplement, 
resulting in approximately 30% of energy intake from protein, 40% of energy from carbohydrate 
and 30% of energy from fat. The CARB diet was aimed at providing 0.8 g/kg/d protein or 
approximately 18% of energy from protein, 52% of energy from carbohydrate (~182 g/d) and 
30% of energy from fat, with an additional 50 g/d of carbohydrate from the supplement.  
 Participants were asked to attend diet education classes taught by a registered dietitian 
every 2 weeks during the 6 mo weight loss program. Diet education was based on healthy eating 
guidelines according to the USDA My Pyramid (21). The registered dietitian also provided 
personal feedback monthly to each participant, adjusting energy intake and portions when 
needed to ensure weight loss. Participants were provided with meal plans and food scales (A&D 
Weighing, Model SK2000, San Jose, CA, USA) to weigh their food and control portions. Diet 
education and meal plans were the same for both PRO and CARB groups, and were designed to 
provide 1400 kcal/d, with a goal of 10% weight loss over 6 mo. The whey protein and 
maltodextrin supplements provided an additional 160 kcal/d. Participants were also provided 
with a multivitamin and a calcium and vitamin D supplement to be taken every day.  
 Post-intervention testing was conducted 6-8 mo after the start of the intervention and diet 
and exercise treatments were continued until completion of measurements. Adherence to the diet 
was monitored by measuring body weight monthly and by self-reported weight weekly. Online 
food records were obtained monthly to track food intake and provide feedback to participants. 
Three-day weighed food diaries were collected for research purposes at baseline, month 3 and 
post-intervention, and were reviewed by the dietitian for completeness. All 3-day food diaries 
were analyzed by the same student using Nutritionist Pro commercial software version 4.1 
(Axxya Systems, Stafford TX, USA). Used supplement containers were collected and unused 
supplement was weighed to assess compliance to the supplement component of the treatment.  
 Exercise treatment. Supervised exercise classes were provided 5 d/wk, of which 
participants were required to attend 2-3 exercise classes/wk. Exercise consisted of 20 min of 
flexibility exercises and 20-30 min of low to moderate intensity walking on an indoor track. 
Prescribed exercise was the same for both PRO and CARB groups. Participants recorded weekly 
exercise and rate of perceived exertion (RPE) at classes. Participants were also provided a 
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pedometer (Accusplit AE170XLGM, Pleasanton, CA, USA), and were asked to record total daily 
steps over 7 consecutive days monthly.  
 Body composition. Height was measured at baseline and post-intervention to the nearest 
0.1 cm with a digital stadiometer (Seca model 242, Hanover, MD, USA). Weight was measured 
monthly to the nearest 0.1 kg with a digital scale (Tanita, Model BWB-627 A, Arlington 
Heights, IL, USA). Body mass index (BMI) was calculated as weight (kg) divided by height 
(m
2
). Waist and hip circumferences were measured monthly to the nearest 0.1 cm with a Gulick 
II retractable measuring tape (Country Technology Inc., Gay Mills, WI, USA).  
 Whole body fat mass (FM) and whole body relative fat (%Fat) were measured using dual 
energy X-ray absorptiometry (DXA; Hologic Discovery, software version 12.7.3, Waltham, MA, 
USA). Regions of interest were drawn in the trunk from T11 to L5 vertebrae for analysis of 
abdominal fat and %Fat. Participants wore light-weight clothing and removed all jewelry. All 
DXA scans were analyzed by the same technician. The DXA machine was calibrated daily using 
manufacturer phantoms. Precision for DXA measurements of interest is between 1 and 1.5% in 
our laboratory.   
 Magnetic resonance imaging (MRI) was used to measure subcutaneous (SAT) and 
intermuscular adipose tissue (IMAT) of the right thigh. For this study, IMAT is defined as 
adipose tissue located beneath the fascia lata and between muscle groups (Shen et al. 2003; 
Gallagher et al. 2005). All imaging was performed on a 1.5T General Electric Signa Excite 
whole-body scanner (Milwaukee, WI, USA) using a phased array torso coil strapped around the 
thigh of interest. A spoiled gradient-recalled echo sequence was used to acquire in- and out-of-
phase images for a two-point Dixon fat separation technique (22). Images were acquired in 10 
mm slices over the middle third of the participant’s femur (14-16 slices), as measured from the 
distal and proximal endpoints of the femur in the scouting scan. A field of view of 48 cm and 
matrix size of 256x256 resulted in an in-plane resolution of 1.875 mm. Determination of SAT 
and IMAT quantities was performed by segmenting the depots in the fat-only image, and region 
growing was used to determine the threshold. All images were analyzed by the same operator 
using Amira 5.2 (Visage Imaging Inc., San Diego, CA, USA). 
 Indicators of metabolic disease risk. Blood samples were obtained at baseline, month 1 
and post-intervention, following an overnight 12 h fast. To ensure that the participant was 
healthy (i.e. free of acute inflammation) at the time of sampling, the blood draw was repeated if 
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the participant reported symptoms of illness or sickness at the draw or within 7 days post-draw. 
Only data from baseline and post-intervention are presented. Plasma samples were sent to an 
external medical laboratory (Provena Covenant Medical Center, Champaign, IL, USA) for 
measurement of fasting glucose concentrations. Serum insulin concentrations were measured 
using a commercial radioimmunoassay kit (ImmuChem, MP Biomedicals LLC, Solon, OH, 
USA). The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was calculated as 
(fasting insulin x fasting glucose) / 405 (23). C-reactive protein (CRP) and interleukin 6 (IL-6) 
were measured using commercial high-sensitivity ELISA kits (CRP: Diagnostic Automation 
Inc., Calabasas, CA, USA; IL-6: Quantikine HS, R&D Systems, Minneapolis, MN, USA). Inter-
assay CVs for CRP and IL-6 were 9.2% and 14.5%, respectively; intra-assay CVs for CRP, IL-6 
and insulin were 1.0%, 5.0% and 1.4%, respectively. Blood pressure was measured in duplicate 
after sitting quietly for 10 min using a semi-automated blood pressure monitor (Dynamap PRO 
100).  
 Statistical analysis. All data analyses were conducted using SPSS version 17.0 (Chicago, 
IL, USA). Only data for participants who completed post-intervention tests were included in the 
analysis. Data were assessed for normality using the Shapiro-Wilk statistic. Nonparametric tests 
were used for data that did not meet the assumption of normality. CRP and IL-6 data were 
normally distributed only after exclusion of two outliers (>400% increase from pre- to post-
intervention), therefore these were excluded from analyses on inflammation levels. Change 
variables were calculated for the difference in values between PRO and CARB groups relative to 
baseline values. Baseline and change variables were compared between PRO and CARB groups 
using Student’s independent t-test. T-tests were also conducted using two combinations of 
compliance criteria: 1) weight loss within the 75
th
 percentile of most weight lost; and either 2a) 
supplement consumption >50% of prescribed amount (PRO n=12, CARB n=7), or 2b) protein 
intake >1.1 g/kg/d for PRO and carbohydrate intake >52%E (PRO n=8, CARB n=5). Linear 
regression analyses were used to assess independent associations between fat depots and specific 
indicators of metabolic disease risk. An α-level of 0.05 was considered significant. Results are 
expressed as mean±SD. 
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3.3 Results 
 Of the 31 women that enrolled in the study, 26 (84%; 13 PRO, 13 CARB; 25 Caucasian, 
1 African American) completed post-intervention measurement. Three participants withdrew due 
to health issues, and two withdrew for other personal reasons (Figure 2). Twelve of the 26 
completers (46%; PRO n=5, CARB n=7) reported regular use of non-steroidal anti-inflammatory 
medications, and 16 (62%; PRO n=7, CARB n=9) used statins. Dose per week of anti-
inflammatory medications and statins was calculated as a covariate in data analyses. Sixteen 
women (62%; PRO n=9, CARB n=7) reported having mild or moderate arthritis in hands, back, 
or legs. Arthritis was included as a dummy variable in data analyses.  
 Baseline variables for body composition and indicators of metabolic disease risk did not 
differ between PRO and CARB (Tables 1, 3 and 4). Of baseline dietary macronutrients, 
carbohydrate and fat intake as a percentage of energy intake (%E) differed between groups with 
a +7.7% difference in %E carbohydrate intake and -7.2% lower %E fat intake in the PRO group.  
 Diet education class adherence was 81.4±19.2% and 71.3±22.2% (p=0.23) and exercise 
class attendance was 87.9±12.2% and 78.6±14.9% (p=0.09) for PRO and CARB, respectively. 
On a scale where 6 is extremely easy and 20 is extremely hard, mean RPE over 6 mo of exercise 
classes was 12.9±1.7 and 12.3±1.2 (p=0.38) for PRO and CARB, respectively. Baseline 
pedometer step count was 5901±2875 steps and 4108±1484 steps (p=0.07), post-intervention 
6463±3217 steps and 6652±2708 steps (p=0.88) and change in pedometer steps relative to 
baseline +28.8±79.2% and +55.7±40.6% (p=0.35), for PRO and CARB, respectively.    
 Mean supplement intake over 6 mo was 41.5±6.5 g/d (77.5% of prescribed supplement) 
for PRO and 38.2±10.8 g/d (74.8% of prescribed supplement) for CARB, and did not differ 
between groups (p=0.36). Total post-intervention energy and macronutrient intake, displayed in 
Table 2, includes intake from both diet and supplement combined. Energy intake differed 
between groups at post-intervention, however, when taking post-intervention weight into 
account, intake was not different (20.6±4.7 and 21.1±4.8 kcal/kg body weight, for PRO and 
CARB, respectively; p=0.50). As intended by study design, total protein intake was greater for 
PRO and total carbohydrate intake was greater for CARB when on treatment. At post-
intervention, PRO ingested 1.20±0.14 g/kg/d protein compared to 0.86±0.20 g/kg/d for CARB 
(p<0.001). Fat intake and %E fat intake were less for PRO compared to CARB, (both p<0.05); 
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however, the % change from baseline did not differ likely somewhat influenced by the higher 
%E fat intake in CARB at baseline (p<0.05).   
 Twenty-three % of participants (6 of 26) reduced their weight 10% or more from 
baseline; 54% (14 of 26) reduced initial weight by 3-9%; and the remaining 23% reduced their 
weight by 1% or less. Mean weight decreased after 6 months in both groups, with a strong trend 
for a greater decrease in the PRO group compared to CARB (3.9% difference, p=0.059; Table 1). 
PRO had greater reductions in all fat or adipose depots, except IMAT relative to muscle volume; 
however, only reductions in abdominal fat mass, thigh SAT and IMAT volume were 
significantly greater in PRO compared to CARB (Table 3). No significant changes between 
groups were found in any of the indicators of metabolic disease risk (Table 4). Although changes 
in weight, fat mass or adipose tissue and metabolic indicators were greater in the PRO group, 
they did not differ significantly between PRO and CARB groups when using any of the 
compliance criteria, possibly due to reduced sample size (data not shown).  
 Linear regression analyses indicated that % change in SAT volume was an independent 
predictor of % change in CRP explaining 30% of the variance, when adjusting for PRO vs. 
CARB and use of anti-inflammatory medication (Table 5b). Covarying for anti-inflammatory 
dose per week resulted in a better model fit than covarying for statin dose per week (data not 
shown). Relative change in abdominal fat mass showed a trend towards independently predicting 
% change in CRP (p=0.057). Changes in any depot of fat or adipose did not predict % change in 
HOMA-IR, nor did supplement group alone predict % change of either HOMA-IR or CRP. 
 
3.4 Discussion 
 The primary novel finding in this study is that higher protein intake leads to greater 
reductions in IMAT. However, when accounting for changes in muscle volume, IMAT actually 
increases albeit not significantly and changes are not different between PRO and CARB. 
Changes in abdominal fat and SAT are also impacted by level of protein intake, with greater 
protein intake resulting in greater fat loss. Furthermore, although indicators of metabolic disease 
risk did not differ between groups, it appears that changes in abdominal fat and SAT can mediate 
positive effects on inflammation metabolic disease risk. Effect sizes, which were within a 
moderate range, suggest that statistically significant differences between groups in the primary 
outcomes may have been reached with a larger sample size.  
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  Greater protein intake contributed to more successful weight loss compared to greater 
carbohydrate intake in this study, in terms of percentage of women who lost weight as well as 
average weight lost, which is similar to other studies with middle-aged and older adults (16-19, 
24-25) but conflicts with other findings (19-20, 26). Studies assessing the effect of higher protein 
intake on weight loss vary in duration, from 2-3 mo (16-17, 26-27) to 6 mo (24-25); and in level 
of protein, ranging from 24 %E (84 g/d) (17) to ~30 %E (115 g/d) (16, 18-20, 27). Long-term 
follow-ups indicate that although some weight may be regained, weight loss is better maintained 
following a moderate to high protein intake (24, 27). Findings from our study confirm that 
longer-term trials are necessary to show significant weight changes, but that a moderate protein 
intake, 27% (92 g/d), may be sufficient for maintaining this weight loss over a long period.  
 Notably, our study design was unique compared with previous research, in that higher 
protein intake was attained via a powder supplement that could be mixed in with foods or 
beverages, rather than via diet education on eating more protein-rich foods. Thus we were able to 
reduce bias from assessing protein intake via diet records, and better control actual ingested 
protein intake. In addition, in our study, timing of protein intake was controlled and about 22g of 
whey protein was consumed with breakfast foods, while the rest of the supplement was 
consumed often as an afternoon snack, and dietary protein consumed at meals. Timing of protein 
ingestion may be important for maximizing the beneficial effects on weight management (28-
29). A proposed mechanism for improved weight management with higher protein intake is 
increased satiety resulting in decreased energy intake (30). Distributing protein intake throughout 
the day may have beneficially influenced satiety in our study potentially promoting greater 
weight loss, as seen in post-intervention energy intake levels which were lower for PRO 
compared with CARB, which is similar to previous findings (24-25). Interestingly, total protein 
intake (dietary + supplement) increased in the PRO group by only ~16 g/d, despite 
supplementary protein intake averaging at 42 g/d. A closer examination reveals that the whey 
protein supplement displaced dietary protein intake in the PRO group such that a ~18 g/d 
decrease is seen in dietary protein intake from baseline to post-intervention.  
 Similarly to weight loss, many studies show greater loss of fat mass (16-19, 25) with 
higher protein intake, but not all findings are consistent (20). In our study, the PRO group clearly 
lost more fat mass (effect size = 0.6), but due to a small sample size, only differences in 
abdominal fat, SAT and IMAT were significant between PRO and CARB. Interestingly, IMAT 
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decreased with weight loss, and decreased more in the PRO group, but naturally, changes in 
IMAT are dependent on changes in the surrounding muscle. When IMAT was expressed as 
relative to muscle volume, not only were there no longer differences between groups, but relative 
IMAT increased. To our knowledge, IMAT has not been previously measured under weight loss 
conditions, and an important question remains whether absolute or relative IMAT has more 
clinical significance.   
 Similarly to previous higher protein weight loss studies (17-18, 20, 24, 27), although 
metabolic profile improved following weight loss, no significant effect of dietary treatment was 
detected, possibly due to large variability. Carbohydrate intake was well above the 10-20 %E 
(~100 g/d) in the PRO group, and therefore is not considered a restricted carbohydrate diet, 
which is thought to also have beneficial effects on cardiovascular disease risk (31). CRP has 
been found to be associated with changes in FM following a high protein weight loss diet (32). 
We found changes specifically in abdominal fat and SAT to independently predict changes in 
inflammation. Therefore, greater reductions in these fat depots from a higher protein diet may 
mediate decreases in inflammation, which in turn is known to impact risk for metabolic 
syndrome (33), cardiovascular disease (34-36) and type 2 diabetes (2). This question is of high 
public interest and requires further study.   
 This small pilot study, although innovative, does have limitations. The main limitation in 
this study was the small sample size. However, effect sizes calculated for body composition and 
metabolic markers in this study, ranging from 0.09 (SAT) to 0.77 (IMAT) for body composition 
outcomes and from 0.21 (insulin) to 0.54 (CRP) for metabolic markers, indicate that with a larger 
sample size significant differences between groups would have been more apparent (37). Thus, 
this study serves as excellent preliminary data for further research assessing the effects of protein 
intake on health status under weight loss conditions in older women.  
 As with all clinical trials investigating behavioral interventions, adherence and 
compliance is an issue. Although withdrawal rate was relatively low (16%) compared with most 
other clinical trials, when evaluated in conjunction with supplement compliance (75%), the effect 
was present although not well characterized. Indeed, although this trial was designed as an 
efficacy trial and not an effectiveness trial, it should be noted that both withdrawal and 
supplement compliance was similar between the groups. Exclusion of data based on compliance 
criteria, such as weight loss, supplement intake and adherence to dietary guidelines, can also be 
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problematic in a small trial as it not only decreases the sample size but also reduces 
generalizability and can create bias. For example, including only data that met compliance 
criteria in this study resulted in more samples excluded from the CARB group, as the PRO group 
was overall more successful with weight loss, similar to previous reports (19). Therefore, in this 
case, excluding subjects based on weight loss criteria may lead to potential bias and type 2 error.  
 In conclusion, our findings support increasing protein levels in reduced calorie diets to 
promote weight loss, reduce fat mass and adipose tissue and potentially improve metabolic 
profile risk. Effects of a higher protein weight loss diet on improvements in insulin sensitivity, 
glucose tolerance and inflammation may become more apparent in a higher risk population, such 
as in people with metabolic syndrome, cardiovascular disease or type 2 diabetes. Lastly, we 
show that using a powdered supplement to increase protein intake as part of a weight loss diet is 
acceptable to an older population, instead of increasing consumption of protein-rich foods, which 
may be more difficult for older individuals to ingest and may have a higher fat content. 
Nevertheless, longer-term studies with larger sample sizes are needed to confirm the feasibility 
of maintaining these optimal changes beyond six months.  
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Figure 2. Study design flow chart. PRO = higher protein weight loss diet; CARB = higher 
carbohydrate weight loss diet.  
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Table 1. Descriptive characteristics of participants (PRO n= 13, CARB n= 13) represented as 
mean±SD. 
 Group Baseline P-value* Post-intervention % Change† P-value‡ 
Age PRO 64.77±4.4  - -  
 CARB 64.6±5.2 0.936 - - - 
Height (cm) PRO 161.9±4.9  - -  
 CARB 162.7±5.7 0.678 - - - 
Weight (kg) PRO 84.7±10.5  77.7±9.35 -8.0±6.2  
 CARB 86.8±13.4 0.655 83.3±13.7 -4.1±3.6 0.059 
BMI (kg/m
2
) PRO 32.3±3.9  29.8±3.7 -7.6±6.2  
 CARB 32.7±4.2 0.804 31.5±4.6 -3.9±3.7 0.075 
* P-value for difference in baseline values between PRO and CARB groups.  
†% Change = change from baseline relative to baseline value [(post-intervention – baseline) / 
baseline]. 
‡ P-value for difference in % Change between PRO and CARB groups. 
SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet; BMI = body mass index.  
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Table 2. Dietary energy and macronutrient intake data, and total energy and macronutrient 
including supplement (PRO n=11, CARB n=12) represented as mean±SD. 
 Group Energy 
intake 
(kcal/d) 
Protein intake Carbohydrate intake Fat intake 
(g/d) (g/kg/d) (%E) (g/d) (%E) (g/d) (%E) 
Dietary 
baseline 
PRO 1687±264 76.2±24.0 0.91±0.23 18.6±7.4 220.0±47.5 52.1±7.5 56.2±18.5 29.5±6.0 
 CARB 1743±321 81.4±18.6 0.98±0.25 18.8±3.6 190.9±49.8 44.4±9.1* 71.4±19.6 36.7±6.9* 
          
Dietary during 
intervention 
PRO 1221±228 58.5±13.3 0.76±0.13 19.4±4.1 169.0±24.5 56.1±7.5 35.3±12.0 25.6±5.7 
 CARB 1484±367 71.0±13.7 0.87±0.20 19.8±4.2 178.3±47.3 48.8±10.2 53.8±23.4 31.5±7.6 
          
Total during 
intervention§  
PRO 1369±197 91.8±12.6 1.21±0.14 27.3±5.3 169.0±24.5 49.6±5.6 35.3±12.0 22.8±5.6 
 CARB 1627±388* 71.0±13.7* 0.87±0.20* 17.9±3.5* 217.8±53.6* 54.2±9.8 53.8±23.4* 28.8±7.4* 
% Change† PRO -18.1±18.8 27.5±29.4 40.5±33.8 61.3±44.8 -19.6±26.0 -2.3±18.6 -34.1±31.9 -22.4±24.7 
 CARB -6.0±30.3 -9.8±26.0 -5.8±26.9 0.1±30.6 17.2±41.1 26.8±35.9 -20.3±47.6 -18.8±25.7 
p-value‡  0.295 0.004 0.001 0.001 0.019 0.014 0.622 0.737 
* Significant difference in values between PRO and CARB groups within the same time point, 
p<0.05. 
†
 % Change = change from baseline relative to baseline value [(during intervention including 
supplement – baseline) / baseline]. 
‡
 p-value for difference in % Change between PRO and CARB groups. 
§
 Includes mean supplement and dietary intake per day assessed at month 6 of intervention.  
SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet.  
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Table 3. Changes in fat mass and adipose volume in response to the intervention (DXA: PRO 
n=13, CARB n=13; MRI: PRO n=12, CARB n=12), represented as mean±SD.  
 Group Baseline Post-intervention % Change* P-value† 
DXA whole body fat mass (kg) PRO 36.5±6.6 30.6±8.7 -15.4±17.8  
 CARB 37.4±8.3 36.0±9.1 -6.1±5.4 0.091 
DXA whole body %fat PRO 42.4±3.2 39.7±4.6 -6.3±7.0  
 CARB 42.5±4.1 41.8±4.6 -2.6±3.7 0.101 
DXA abdominal fat mass (kg) PRO 5.8±1.7 4.8±1.7 -14.8±15.0  
 CARB 5.7±1.9 5.5±2.2 -4.1±8.1 0.037 
DXA abdominal %fat PRO 40.4±6.0 36.9±8.6 -8.1±12.2  
 CARB 40.5±6.9 39.6±8.7 -2.0±6.7 0.133 
      
MRI thigh subcutaneous fat (m
3
) PRO 2.20±5.5 1.82±5.0 -18.8±13.5  
 CARB 2.45±8.3 2.37±7.4 -7.9±6.9 0.024 
MRI thigh IMAT (m
3
) PRO 0.23±0.04 0.21±0.03 -9.2±9.4  
 CARB 0.23±0.06 0.23±0.06 -1.0±7.7 0.028 
MRI Thigh IMAT (% of muscle) PRO 5.95±0.94 6.22±1.08 4.7±5.8  
 CARB 5.62±0.83 5.63±0.45 4.3±8.6 0.883 
* % Change = change from baseline relative to baseline value [(post-intervention – baseline) / 
baseline]. 
†P-value for difference in % Change between PRO and CARB groups.  
SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet; DXA = dual energy X-ray absorptiometry; 
whole body %fat = whole body fat mass/whole body mass; abdominal %fat = abdominal fat 
mass/abdominal mass; MRI = magnetic resonance imaging; IMAT = intermuscular adipose 
tissue.  
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Table 4. Indicators of metabolic disease risk (PRO n=13, CARB n=13) represented as mean±SD. 
 Group Baseline Post-intervention % Change* P-value† 
Fasting insulin (µIU/ml) PRO 38.0±25.2 25.2±9.5 -24.0±26.8  
 CARB 36.6±23.3 27.4±11.6 -13.1±30.0 0.338 
Fasting glucose (mg/dl) PRO 96.4±14.0 90.9±9.6 -4.6±11.8  
 CARB 96.9±10.8 94.7±11.2 -2.1±6.6 0.515 
HOMA-IR PRO 9.35±6.69 5.70±2.29 -26.7±30.3  
 CARB 9.08±6.59 6.64±3.38 -14.2±32.4 0.319 
CRP
‡
 (mg/l) PRO 2.53±1.96 2.12±1.85 -25.7±53.4  
 CARB 2.88±1.51 3.14±1.93 3.9±51.4 0.179 
IL-6
‡
 (pg/ml) PRO 1.37±0.89 1.38±0.98 -3.4±44.7  
 CARB 1.18±0.56 1.12±0.47 1.2±37.5 0.564 
Systolic blood pressure (mmHg) PRO 134±15 127±9 -3.7±10.2  
 CARB 148±18 138±21 -6.9±8.9 0.441 
Diastolic blood pressure (mmHg) PRO 79±7 73±5 -5.6±6.8  
 CARB 80±8 78±11 -2.7±9.8 0.422 
Waist circumference (cm) PRO 97.6±9.3 91.2±9.7  -6.4±4.5  
 CARB 96.6±9.0 92.8±11.3 -4.1±4.04 0.177 
Waist-to-hip ratio PRO 0.83±0.06 0.80±0.05 -3.4±2.6  
 CARB 0.81±0.07 0.78±0.06 -3.0±4.4 0.756 
* % Change = change from baseline relative to baseline value [(post-intervention – baseline) / 
baseline]. 
†P-value for difference in % Change between PRO and CARB groups. 
‡ Outliers excluded (PRO n=12, CARB n=12). 
SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet; HOMA-IR = homeostasis model assessment 
of insulin resistance; CRP = C-reactive protein; IL-6 = interleukin 6. 
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Table 5a. Regression analyses: % change in HOMA as dependent variable (outliers excluded; 
PRO n=12, CARB n=12).  
 Variable Adjusted R
2 
Model p-value 
Standardized 
β-coefficient 
p-value 
Model 1 Supplement group* 0.037 0.179 -0.277 0.179 
Model 2 Supplement group* 0.146 0.177 -0.173 0.424 
 WB fat mass
†
   0.282 0.197 
Model 3 Supplement group* 0.056 0.203 -0.172 0.434 
 Abdominal fat mass
†
   0.263 0.237 
Model 4 Supplement group* 0.050 0.230 -0.126 0.612 
 SAT volume
†
   0.288 0.253 
Model 5 Supplement group* 0.052 0.227 -0.128 0.605 
 IMAT volume
†
   0.289 0.248 
* PRO = 1, CARB = 0.  
† % Change from baseline relative to baseline value [(post-intervention – baseline) / baseline] as 
independent variables. 
PRO = higher protein, lower carbohydrate weight loss diet; CARB = higher carbohydrate, lower 
protein weight loss diet; HOMA = homeostasis model assessment of insulin resistance; WB = 
whole body; SAT = subcutaneous adipose tissue; IMAT = intermuscular adipose tissue.  
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Table 5b. Regression analyses: % change in CRP as dependent variable (outliers excluded; PRO 
n=12, CARB n=12) 
 Variable Adjusted R
2 
Model p-value 
Standardized 
β-coefficient 
p-value 
Model 1 Supplement group* 0.075 0.100 -0.336 0.100 
Model 2a Supplement group* 0.114 0.101 -0.227 0.284 
 WB fat mass
†
   0.295 0.168 
Model 2b Supplement group 0.154 0.091 -0.273 0.196 
 WB fat mass
†
   0.297 0.157 
 Anti-inflammatory meds
‡
   -0.272 0.169 
Model 3a Supplement group* 0.182 0.042 -0.175 0.394 
 Abdominal fat mass
†
   0.404 0.057 
Model 3b Supplement group* 0.208 0.049 -0.225 0.278 
 Abdominal fat mass
†
   0.384 0.067 
 Anti-inflammatory meds
‡
   -0.242 0.204 
Model 4a Supplement group* 0.282 0.014 -0.037 0.863 
 SAT volume
†
   0.568 0.015 
Model 4b Supplement group* 0.299 0.021 -0.089 0.682 
 SAT volume
†
   0.543 0.019 
 Anti-inflammatory meds
‡
   -0.224 0.234 
Model 5a Supplement group* 0.046 0.241 -0.252 0.313 
 IMAT volume
†
   0.163 0.511 
Model 5b Supplement group* 0.085 0.205 -0.288 0.246 
 IMAT volume
†
   0.188 0.442 
 Anti-inflammatory meds
‡
   -0.282 0.190 
* PRO = 1, CARB = 0.  
† % Change from baseline relative to baseline value [(post-intervention – baseline) / baseline] as 
independent variables. 
‡ Post-intervention anti-inflammatory medication used as independent variable.  
PRO = higher protein, lower carbohydrate weight loss diet; CARB = higher carbohydrate, lower 
protein weight loss diet; CRP =  C-reactive protein; WB = whole body; SAT = subcutaneous 
adipose tissue; IMAT = intermuscular adipose tissue.  
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CHAPTER 4 
The Effects of a Higher Protein Intake During Energy Restriction on  
Changes in Lean Soft Tissue, Muscle and Physical Function in 
Postmenopausal Women  
 
4.1 Introduction 
 Aging is associated with not only increased adiposity, but also decreased skeletal muscle 
mass (1). These age-related changes in body composition can result in decreased muscle strength 
and quality (2-3), mobility limitations (4), an inability to perform daily activities (5) and a 
greater risk for physical disability (6-7). Gender inequity exists with regard to body composition 
and physical function as older women have greater adiposity (8-9), less lean mass (8-9), lower 
muscle quality (8, 10), poorer balance and gait than men of a similar age (11-13), as well as a 
greater prevalence for falls and risk of physical disability (14-15).  
  Although limited data is available on effects of intentional weight loss in obese and 
overweight individuals on physical function and risk of disability in older adults, evidence 
suggests that intentional weight loss may improve physical performance (16-18). This issue is as 
yet controversial in the elderly specifically, as weight loss is known to lead to reductions in 
muscle and decreases in muscle strength (3, 19). 
 Increasing dietary protein intake in a reduced calorie diet may help maintain muscle mass 
during weight loss, and subsequently convey a beneficial effect on physical function. Emerging 
data from the Health ABC Study indicate that older adults consuming greater amounts of protein 
are less likely to lose lean mass over time (20). Early studies on nitrogen balance in obese 
individuals undergoing weight loss showed that the current Recommended Dietary Allowance 
(RDA) for protein is insufficient to support nitrogen equilibrium (21-22). Levels of protein 
intake of 1.5-1.6 g/kg body weight/d (21, 23), or 25-30% of energy intake (23-24) have been 
suggested for improved weight loss and maintenance of muscle mass. Moreover, incorporating 
exercise with a higher protein weight loss diet appears to have additive effects for optimizing 
changes in body composition (25).  
  The American Society for Nutrition and NAASO, The Obesity Society, specifically 
recommend weight loss therapies that maximize fat mass loss and minimize skeletal muscle loss 
in order to maintain physical function and independence in older adult cohorts (1). However, 
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consensus on the most appropriate weight loss regimen and the body composition variable most 
predictive of beneficial changes in physical function for this population has not been adequately 
characterized.  
 In this context, the primary aim of this study was to assess the effect of a higher protein, 
lower carbohydrate (PRO) weight loss diet on lean soft tissue (LST), muscle and physical 
function, compared with a conventional higher carbohydrate, lower protein weight loss diet 
(CARB). The secondary aim was to identify measures of muscle quality that best predict changes 
in physical function, characterized by strength, balance and physical performance. We 
hypothesized that a PRO weight loss diet would result in attenuation of lean mass loss compared 
with an isocaloric CARB diet, and that these changes may convey beneficial effects on physical 
function. To our knowledge, no studies have previously assessed the effects of a higher protein 
intake on physical function in older individuals undergoing intentional weight loss. Findings 
from this study will contribute to the understanding of the optimal macronutrient composition of 
weight loss diets for maintaining lean soft tissue, muscle and physical function in older 
individuals. 
 
4.2 Methods 
 Study design and participants. Thirty-one healthy, overweight or obese postmenopausal 
women (mean age±SD: 65.2±4.6 yrs; 29 Caucasian, 1 African American, 1 Latina) were 
recruited from the community for a 6 month double-blind, randomized weight loss trial. 
Exclusion criteria were as follows: BMI <28 kg/m
2
; >300 lb weight; major weight change 
defined as >5 lb change in the prior 6 mo; postmenopausal <5 yrs; regular physical activity >1 
h/wk or >2 sessions/wk in the prior 6 mo; regular smoking within the prior 10 yrs; history of 
conditions that impact the primary outcomes such as cancer, cardiovascular disease, type 2 
diabetes, renal disease, musculoskeletal or neuromuscular impairments; and use of medications 
that may impact bone metabolism, such as hormone replacement therapy or osteoporosis drugs, 
within the prior 2 years. Health history was obtained with a questionnaire, which included items 
on medications, supplements and history of conditions other than ones listed as exclusion 
criteria. Participants were screened with standard blood tests (comprehensive metabolic panel 
and complete blood count). All participants were required to provide personal physician 
clearance prior to enrollment. All participants signed a consent form approved by the University 
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of Illinois Institutional Review Board upon enrollment in the study. Participants were blocked on 
age and BMI with subsequent random assignment to either PRO or CARB treatment. 
Researchers and participants were blinded to which treatment, PRO or CARB, the participants 
received. 
 Dietary treatment. Participants were provided with a supplement: the PRO group 
received 50 g/d of 90% whey protein isolate, and the CARB group received 50g/d of 
maltodextrin. Participants were asked to ingest half (25g) of the supplement in the morning with 
breakfast and the other half in the afternoon or evening. The PRO diet prescribed was designed 
to provide 0.8 g/kg/d of dietary protein with an additional 45g/d of protein from the supplement, 
resulting in approximately 30% of energy intake from protein, 40% of energy from carbohydrate 
and 30% of energy from fat. The CARB diet was aimed at providing 0.8 g/kg/d protein or 
approximately 18% of energy from protein, 52% of energy from carbohydrate (~182 g/d) and 
30% of energy from fat, with an additional 50 g/d of carbohydrate from the supplement.  
 Participants were asked to attend diet education classes taught by a registered dietitian 
every 2 weeks during the 6 mo weight loss program. Diet education was based on healthy eating 
guidelines according to the USDA My Pyramid (26). The registered dietitian also provided 
personal feedback monthly to each participant, adjusting energy intake and portions when 
needed to ensure weight loss. Participants were provided with meal plans and food scales (A&D 
Weighing, Model SK2000, San Jose, CA, USA) to weigh their food and control portions. Diet 
education and meal plans were the same for both PRO and CARB groups, and were designed to 
decrease daily energy intake by approximately 500 kcal/d, with a goal of 10% weight loss over 6 
mo. Participants were also provided with a one-a-day multivitamin and a calcium and vitamin D 
supplement to be taken every day.  
 Adherence to the diet was monitored by measuring body weight monthly and by self-
reported weight weekly. Online food records were obtained monthly to track food intake and 
provide feedback to participants. Three-day weighed food diaries were collected for research 
purposes at baseline, month 3 and post-intervention, and were reviewed by the dietitian for 
completeness. All 3-day food diaries were analyzed by the same student using Nutritionist Pro 
commercial software version 4.1 (Axxya Systems, Stafford TX, USA). Used supplement 
containers were collected and unused supplement was weighed to assess compliance to the 
supplement component of the treatment.  
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 Exercise treatment. Supervised exercise classes were provided 5 d/wk, of which 
participants were required to attend 2-3 exercise classes/wk. Exercise consisted of 20 min of 
flexibility exercises and 20-30 min of low to moderate intensity walking on an indoor track. 
Prescribed exercise was the same for both PRO and CARB groups. Participants recorded daily 
minutes walked at exercises classes and rate of perceived exertion (RPE) at classes. RPE scale 
ranged from 6 (extremely easy) to 20 (extremely hard). Participants were also provided a 
pedometer (Accusplit AE170XLGM, Pleasanton, CA, USA), and were asked to record total daily 
steps over 7 consecutive days monthly.  
 Body composition. Height was measured at baseline and post-intervention to the nearest 
0.1 cm with a digital stadiometer (Seca, Model 242, Hanover, MD, USA). Weight was measured 
monthly to the nearest 0.1 kg with a digital scale (Tanita, Model BWB-627 A, Arlington 
Heights, IL, USA). Body mass index (BMI) was calculated as weight (kg) divided by height 
(m
2
). Leg length, waist and hip circumferences were measured monthly to the nearest 0.1 cm 
with a Gulick II retractable measuring tape (Country Technology Inc., Gay Mills, WI, USA).  
 Whole body lean soft tissue (LST) and whole body relative LST (%LST) were measured 
using dual energy X-ray absorptiometry (DXA; Hologic Discovery, software version 12.7.3, 
Waltham, MA, USA). Right leg LST and %LST (right leg LST/right leg mass) were obtained 
from the whole body scan. Participants wore light-weight clothing and removed all jewelry. All 
DXA scans were analyzed by the same technician. The DXA machine was calibrated daily using 
manufacturer phantoms. Precision for DXA measurements of interest is between 1 and 1.5% in 
our laboratory.   
 Magnetic resonance imaging (MRI) was used to measure muscle volume of the right 
thigh. All imaging was performed on a 1.5T General Electric Signa Excite whole-body scanner 
(Milwaukee, WI, USA) using a phased array torso coil strapped around the thigh of interest. A 
spoiled gradient-recalled echo sequence was used to acquire in- and out-of-phase images for a 
two-point Dixon fat separation technique (27). Images were acquired in 10 mm slices over the 
middle third of the participant’s femur (14-16 slices), as measured from the distal and proximal 
endpoints of the femur in the scouting scan. A field of view of 48 cm and matrix size of 256x256 
resulted in an in-plane resolution of 1.875 mm. Determination of muscle quantity was performed 
by segmenting in the water-only image, and region-growing was used to determine the threshold. 
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All images were analyzed by the same operator using Amira 5.2 (Visage Imaging Inc., San 
Diego, CA, USA). 
 Muscle strength. Right knee extensor and flexor strength were measured using a Humac 
Norm Isokinetic Dynamometer (Computer Sports Medicine Inc. Stoughton, MA, USA). 
Participants performed voluntary maximal contractions, while seated with back supported and 
the tested thigh strapped down. Isokinetic tests were performed at 60°/s, and the greatest peak 
torque from four repetitions was used for analysis. Isometric tests were performed with the 
dynamometer arm fixed at a 45° angle, with the greatest peak torque of three trials used for 
analysis. The sum of isometric extensor and flexor strength was used for muscle quality indices.  
 Balance. The Star Excursion Balance Test (SEBT) is a standardized protocol that 
challenges unilateral dynamic balance (28). It was performed with the participants standing with 
their right foot in the middle of a ―star‖ formed by eight lines extending out at 45° from each 
other. The participants were asked to reach as far as possible with their left leg along the lines in 
the anterior, posteromedial and posterolateral directions, lightly touch the ground with the distal 
part of their foot and return to a double-leg stance without losing balance. The three best trials 
were averaged and normalized for right leg length.   
 Physical performance. The modified nine-item Physical Performance Test (PPT) was 
used to assess each participant’s level of physical function at baseline (29-30). The PPT 
correlates well with degree of disability, loss of independence and mortality, as well as other 
objective measures of strength balance and aerobic power (31). Items include climbing a flight of 
10 stairs, standing up 5 times from a chair, walking 50 ft, putting on and removing a coat, 
picking up a penny placed 12 inches in front of the dominant foot, lifting a book onto a shelf 12 
inches above shoulder height, climbing up and down 4 flights of stairs, turning 360°, and lastly, 
standing with feet side by side, semi-tandem and full-tandem. Items were completed once and 
scored between 0 and 4, with 36 being a perfect total score, and a participant with a total score 
between 18 and 31 is classified as mildly frail.  
 Other tests of physical performance included the timed up and go and transfer tasks. Up 
and go involved the participant starting seated in a chair, standing up without using their arms, 
walking as quickly as possible around a cone place 2.5 m from the chair, and returning to a 
seated position in the chair. The transfer task involved a timed test where the participant started 
from a standing position, moved to a seated position on the floor and then resumed standing. In 
 48 
 
addition, the 10-stair climb and the chair stand tests were used as independent measures of 
physical performance. These, as well as the stair climb and chair stand tests, were conducted 
twice, and times were averaged.  
 Statistical analysis. All data analyses were conducted using SPSS version 17.0 (Chicago, 
IL, USA). Only data for participants who completed post-intervention tests were included in the 
analysis. Data were assessed for normality using the Shapiro-Wilk statistic. Nonparametric tests 
were used for data that did not meet the assumption of normality. Change variables were 
calculated for the difference in values between PRO and CARB groups relative to baseline 
values. Baseline and change variables were compared between PRO and CARB groups using 
Student’s independent t-test. Linear regression using change variables was used to examine body 
composition determinants of changes in physical function outcomes (strength, balance and 
physical performance). For regression analyses, one outlier was removed to meet the 
assumptions of normality and homoscedasticity. Composite variables were created using 
reliability analysis for 1) balance and 2) physical performance constructs. Both balance (SEBT 
posteromedial and posterolateral reach) and physical performance (up and go, chair stand and 
stair climb) had good internal consistency, with Cronbach’s alphas of 0.88 and 0.70, 
respectively. Z-scores of the measures used in the constructs were then averaged to produce 
balance and physical performance composite variables. An α-level of 0.05 was considered 
significant. Results are expressed as mean±SD. 
 
4.3 Results 
 Of the 31 women that enrolled in the study, 26 (84%; 13 PRO, 13 CARB; 25 Caucasian, 
1 African American) completed post-intervention measurements. Three participants withdrew 
due to health issues, and two withdrew for other personal reasons (Figure 3).  
 Physical activity levels of participants measured by pedometer did not differ between 
PRO and CARB at baseline, nor did level of physical function measured by the PPT (Table 6). 
Of baseline dietary macronutrients, carbohydrate and fat intake as a percentage of energy intake 
(%E) differed between groups with a +7.7% difference in %E carbohydrate intake and -7.2% 
lower %E fat intake in the PRO group (Table 7). Baseline variables for strength, balance, 
physical performance and body composition did not differ between PRO and CARB, except the 
up and go test (p=0.04; Tables 8 and 9).  
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 Diet education class adherence was 81.4±19.2% and 71.3±22.2% (p=0.23) and exercise 
class attendance was 87.9±12.2% and 78.6±14.9% (p=0.09) for PRO and CARB, respectively. 
Walking duration at exercise classes increased for both groups, and although PRO walked 5% 
longer than CARB, this was not statistically different (p=0.13; Table 6). RPE at exercise classes 
increased for PRO but decreased slightly for CARB, trending towards a significant difference 
(p=0.08; Table 6). Pedometer steps increased from baseline to post-intervention for PRO and 
CARB combined (5054±2536 steps/d, 6516±2997 steps/d, p=0.023), and duration of walking at 
exercise classes increased from month 1 to post-intervention (22.9±2.6 min/class, 24.6±3.7 
min/class, p<0.001).  
 Mean supplement intake over 6 mo was 41.5±6.5 g/d (77.5% of prescribed supplement) 
for PRO and 38.2±10.8 g/d (74.8% of prescribed supplement) for CARB, and did not differ 
between groups (p=0.36). Total post-intervention energy and macronutrient intake, displayed in 
Table 2, includes intake from both diet and supplement combined. Energy intake differed 
between groups at post-intervention, however, when taking post-intervention weight into 
account, intake was not different (20.6±4.7 and 21.1±4.8 kcal/kg body weight, for PRO and 
CARB, respectively; p=0.50). As intended by study design, total protein intake was greater for 
PRO and total carbohydrate intake was greater for CARB when on treatment. At post-
intervention, PRO ingested 1.20±0.14 g/kg/d protein compared to 0.86±0.20 g/kg/d for CARB 
(p<0.001). Fat intake and %E fat intake were less for PRO compared to CARB, (both p<0.05); 
however, the % change from baseline did not differ likely somewhat influenced by the higher 
%E fat intake in CARB at baseline (p<0.05).   
 Twenty-three % of participants (6 of 26) reduced their weight 10% or more from 
baseline; 54% (14 of 26) reduced initial weight by 3-9%; and the remaining 23% reduced their 
weight by 1% or less. Mean weight decreased after 6 months in both groups, with a trend for a 
greater decrease in the PRO group compared to CARB (3.9% difference, p=0.059; Table 6).  
 None of the changes in strength, balance or physical performance measures differed 
between PRO and CARB (Table 8), including change in the sum of isometric extensor and flexor 
strengths (p=0.46). Changes in either balance or performance composite variables did not differ 
between PRO and CARB groups (p=0.95, p=0.84, respectively).  
 In PRO and CARB combined, all measures of strength decreased, and balance and 
physical performance improved at post-intervention (Table 8). Isokinetic knee extensor 
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(p=0.001) and flexor (p=0.006), isometric knee flexor strength decreased significantly (p=0.001); 
and anterior reach (p=0.019), posterolateral reach (p<0.001), chair stand (p<0.001), and stair 
climb (p=0.001) improved significantly. Changes in isometric knee extensor (p=0.099), 
posteromedial reach (p=0.058) and transfer test (p=0.064) approached significance.  
 Changes in DXA body composition and muscle quality indices did not differ between 
PRO and CARB, but MRI showed significant changes in muscle volume between groups (Table 
9). PRO lost 4.2% more muscle volume than CARB, but when expressed as relative to thigh 
volume (p=0.01), PRO actually gained 5.8% more muscle than CARB (p=0.049). Furthermore, 
when expressed as a weight to leg LST ratio, there was a beneficial improvement in this ratio in 
PRO compared with CARB (p=0.03).   
 As no differences in the main outcomes were found between PRO and CARB groups, the 
groups were subsequently combined, and linear regression was used to determine whether 
changes in weight and body composition predicted changes in physical function. With respect to 
changes in physical function measures, weight loss contributed to improved performance in up 
and go (p=0.038), transfer test (p=0.028), trended towards improvement in stair climb (p=0.074), 
and decreased strength in isometric knee extensor strength (p=0.041). Of LST and muscle 
measures, changes in weight to leg LST ratio showed a trend towards predicting changes in the 
composite of performance (adjusted r
2
=0.161, p=0.052) and predicted changes in up and go 
(adjusted r
2
=0.189, p=0.02); whereas whole body %LST predicted changes in the composite of 
balance (adjusted r
2
=0.179, p=0.04) and posteromedial reach (adjusted r
2
=0.191, p=0.02). 
 
4.4 Discussion 
 The primary finding in this study confirms previous research and meta-analyses (24-25, 
32-33) showing that a higher protein intake during weight loss, compared to a traditional higher 
carbohydrate, lower protein reduced calorie diet, can help maintain muscle relative to changes in 
adiposity. However, in absolute terms, similarly to reductions in LST and FFM found in other 
studies (34-37), we show that there was actually a greater absolute loss in the PRO group. 
Importantly though, when accounting for greater success with weight loss seen in the PRO group 
by examining relative muscle volume, there is actually a greater net gain of muscle in the PRO 
compared to the CARB group. In this study, the benefit of using MRI in assessing changes in 
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body composition was apparent, as the directions of LST changes were similar when measured 
with DXA.  
Intentional weight loss induced primarily by caloric restriction has been shown to 
decrease thigh muscle volume in 50-60 year old men and women (19), as well as decrease knee 
flexor strength (19). We found a reduction in isometric knee extensor strength, however, in our 
study it appears that this loss of strength was due to weight loss and not to changes in LST or 
muscle, neither absolute or relative to weight. Importantly, despite reduced strength, physical 
performance improved due to weight loss. Weight loss in older adults, even in short-term trials, 
has indeed been found to improve physical performance in both healthy individuals (17-18) and 
those with knee osteoarthritis (16). Incorporating flexibility, endurance and resistance exercise in 
the weight loss program has even greater benefits for both strength (38-39) and physical 
performance (39-42). The volume, intensity and modality of exercise in the current study was 
likely not adequate enough to elicit beneficial effects on strength. Pedometer steps and duration 
of walking at exercise classes increased throughout the course of the study, and although there 
was not a statistical effect of these variables on physical function, increased activity at classes 
and potentially at home may have played a role in improving performance.  
 Developing optimal weight loss programs for decreasing risk of physical disability and 
obesity related disease requires information on body composition changes that best predict 
physical function following weight loss. Very limited data is available, but it has been suggested 
that decreases in fat free mass are associated with improved physical performance, which is 
counter-intuitive (16, 18). In our PRO and CARB combined sample, increases in whole body 
%LST predicted 18-19% of improved balance, and weight to leg LST ratio predicted 16-19% of 
variance of improved composite performance. In cross-sectional studies assessing associations 
between body composition and measures of physical function, women with obese sarcopenia 
have a 3.8 times greater risk for functional limitation than women with greater levels of skeletal 
muscle mass relative to weight (5). Furthermore, lower relative whole body skeletal muscle mass 
is reported to be associated with lower leg strength (5) and poor physical performance (6). 
Overall, it appears that although muscle mass may decrease with weight loss, it is important to 
measure relative muscle mass, and our findings suggest that an increase in %LST with weight 
loss can confer beneficial effects on balance and performance. In addition, thigh muscle 
attenuation (intramyocellular fat accumulation, i.e. a parameter for muscle quality) has been 
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associated with self-reported mobility limitations (4), therefore it may also be important to 
measure changes within the muscle itself.  
 As an indicator of the amount of whole body weight supported by the lower-body, the 
weight to leg LST ratio conceptually has clinical significance for physical function although 
empirical work is limited. Findings from the current study confirm previous results in our 
laboratory, in which relative (i.e. to body mass) leg LST was correlated with physical 
performance in older women (43). We found that the up and go test, in particular, was 
independently predicted by weight to leg LST ratio, suggesting that the relative amount of lower-
body LST to support whole body weight, is important for the ability to perform everyday 
activities. The older female population is known to be at an increased risk for physical disability 
(14-15), therefore losing some of the burden caused by overweight on the leg joints may help 
prevent injuries (44-45), and furthermore, help maintain physical independence with aging (1). 
Although the PRO diet did not directly impact measures of strength, balance or physical 
performance, the change in weight to leg LST ratio differed between PRO and CARB groups, 
indicating, again, that a higher protein intake can help preserve muscle, which in turn has 
beneficial effects on physical performance.  
   The main limitation in this study was the small sample size. However, the small effect 
sizes in this study for physical function measures, ranging from 0.01 (SEBT posteromedial 
reach) to 0.32 (isokinetic knee flexor strength) (46), with the exception of the up and go and 
chair stand tests (effect sizes 0.87 and 0.5, respectively), suggest that our nonsignificant findings 
are not necessarily due to a small sample size. Alternatively, either dietary treatment is not robust 
enough or that the elicited weight change was not of a magnitude to produce changes in these 
outcomes or perhaps the performance measures are not sensitive enough to show potential 
changes in physical function. Promising findings on the importance of protein for maintaining 
relative muscle during weight loss, and the subsequent preservation of %LST to enhance 
physical function provide excellent preliminary data for further research.  
 In conclusion, increasing protein intake during weight loss can offset the deleterious 
effects on muscle mass by maintaining more muscle relative to weight lost. Protein intake levels 
during weight loss do not appear to directly impact physical function. However, the effects of 
weight loss on changes in relative LST appear to play a role in improving balance and physical 
performance. In this older female population, although weight loss negatively impacted strength, 
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the reduced weight helped with other aspects of physical function. This is a significant finding 
for the development of weight loss programs that can improve health while also contributing to 
maintaining independence in older individuals. Including exercise beyond walking and 
flexibility, such as resistance training, will likely prevent some of the strength loss, and further 
improve physical function. Future clinical trials should include both a dietary and an exercise 
weight loss group to determine the most beneficial regimen for improving health, as well as 
strength, balance and performance.  
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Figure 3. Study design flow chart. PRO = higher protein weight loss diet; CARB = higher 
carbohydrate weight loss diet.  
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Table 6. Descriptive characteristics of participants (PRO n= 13, CARB n= 13) represented as 
mean±SD. 
 Group Baseline P-value* Post-intervention % Change† P-value‡ 
Age (yrs) PRO 64.77±4.4  - -  
 CARB 64.6±5.2 0.936 - - - 
Height (cm) PRO 161.9±4.9  - -  
 CARB 162.7±5.7 0.678 - - - 
Weight (kg) PRO 84.7±10.5  77.7±9.35 -8.0±6.2  
 CARB 86.8±13.4 0.655 83.3±13.7 -4.1±3.6 0.059 
BMI (kg/m
2
) PRO 32.3±3.9  29.8±3.7 -7.6±6.2  
 CARB 32.7±4.2 0.804 31.5±4.6 -3.9±3.7 0.075 
Pedometer (steps/d) PRO 5902±2875  6463±3217 28.8±79.2  
 CARB 4108±1484 0.068 6652±2708 55.7±40.6 0.347 
Walking duration in 
exercise class (min) 
PRO 23.6±2.7
§
  25.6±3.8 9.8±7.0  
 CARB 22.7±2.5
§
 0.409 23.7±3.6 4.8±8.1 0.132 
RPE at exercise class PRO 12.3±1.7
§
  13.0±1.9 9.0±13.6  
 CARB 12.5±1.4
§
 0.727 12.2±1.5 -2.0±15.0 0.080 
PPT score PRO 31.6±3.1  32.0±2.6 1.5±10.1  
 CARB 32.7±2.5 0.339 33.9±2.0 2.7±5.3 0.726 
* P-value for difference in baseline values between PRO and CARB groups, p<0.05.  
†% Change = change from baseline relative to baseline value [(post-intervention – baseline) / 
baseline]. 
‡ P-value for difference in % Change between PRO and CARB groups. 
§ Values at month 1 of the intervention.  
SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet; BMI = body mass index; RPE = rate of 
perceived exhaustion; PPT = physical performance test.  
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Table 7. Dietary energy and macronutrient intake data, and total energy and macronutrient 
including supplement (PRO n=11, CARB n=12) represented as mean±SD. 
 Group Energy 
intake 
(kcal/d) 
Protein intake Carbohydrate intake Fat intake 
(g/d) (g/kg/d) (%E) (g/d) (%E) (g/d) (%E) 
Dietary 
baseline 
PRO 1687±264 76.2±24.0 0.91±0.23 18.6±7.4 220.0±47.5 52.1±7.5 56.2±18.5 29.5±6.0 
 CARB 1743±321 81.4±18.6 0.98±0.25 18.8±3.6 190.9±49.8 44.4±9.1* 71.4±19.6 36.7±6.9* 
          
Dietary during 
intervention 
PRO 1221±228 58.5±13.3 0.76±0.13 19.4±4.1 169.0±24.5 56.1±7.5 35.3±12.0 25.6±5.7 
 CARB 1484±367 71.0±13.7 0.87±0.20 19.8±4.2 178.3±47.3 48.8±10.2 53.8±23.4 31.5±7.6 
          
Total during 
intervention§  
PRO 1369±197 91.8±12.6 1.21±0.14 27.3±5.3 169.0±24.5 49.6±5.6 35.3±12.0 22.8±5.6 
 CARB 1627±388* 71.0±13.7* 0.87±0.20* 17.9±3.5* 217.8±53.6* 54.2±9.8 53.8±23.4* 28.8±7.4* 
% Change† PRO -18.1±18.8 27.5±29.4 40.5±33.8 61.3±44.8 -19.6±26.0 -2.3±18.6 -34.1±31.9 -22.4±24.7 
 CARB -6.0±30.3 -9.8±26.0 -5.8±26.9 0.1±30.6 17.2±41.1 26.8±35.9 -20.3±47.6 -18.8±25.7 
p-value‡  0.295 0.004 0.001 0.001 0.019 0.014 0.622 0.737 
* Significant difference in values between PRO and CARB groups within the same time point, 
p<0.05. 
†
 % Change = change from baseline relative to baseline value [(during intervention including 
supplement – baseline) / baseline]. 
‡
 p-value for difference in % Change between PRO and CARB groups. 
§
 Includes mean supplement and dietary intake per day assessed at month 6 of intervention.  
SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet.  
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Table 8. Strength, balance and physical performance outcomes (knee strength: PRO n=11, 
CARB n=13; SEBT: PRO n=12, CARB n=11; physical performance: PRO n=11, CARB n=13) 
represented as mean±SD. 
 Group Baseline Post-intervention % Change* P-value† 
STRENGTH      
Isokinetic knee extensor strength (Nm)
 §
 PRO 94.2±25.7 92.8±18.2 -9.0±14.1  
 CARB 94.8±14.6 87.8±13.3 -7.0±8.5 0.680 
Isokinetic knee flexor strength (Nm)
 §
 PRO 44.5±20.5 44.9±15.1 -7.3±15.0  
 CARB 52.0±15.1 42.5±11.5 -15.2±23.9 0.369 
Isometric knee extensor strength (Nm) PRO 109.7±26.2 111.8±23.2 -4.5±14.8  
 CARB 113.5±23.0 109.5±17.4 -2.0±14.0 0.674 
Isometric knee flexor strength (Nm)
 §
 PRO 57.4±19.0 56.9±16.6 -10.1±11.0  
 CARB 59.2±14.6 49.8±14.4 -15.0±18.9 0.470 
BALANCE      
SEBT anterior reach (%)
§
 PRO 83.0±11.0 88.5±10.4 6.5±9.9  
 CARB 84.5±5.3 87.4±3.5 4.0±8.2 0.519 
SEBT posteromedial reach (%) PRO 65.7±12.3 69.8±12.2 4.9±8.7  
 CARB 65.6±5.4 68.4±7.7 5.0±12.1 0.984 
SEBT posterolateral reach (%)
§
 PRO 51.2±18.3 60.0±13.8 27.8±44.1  
 CARB 48.8±8.9 60.6±8.7 24.7±21.7 0.622 
PHYSICAL PERFORMANCE      
Up and go test (sec) PRO 8.4±1.4 8.0±2.2 -3.2±17.8  
 CARB 7.4±0.9
‡ 6.8±0.7 -7.4±10.8 0.490 
Chair stand test (sec)
 §
 PRO 15.1±3.2 12.9±2.5 -11.9±12.7  
 CARB 13.6±2.4 11.5±1.8 -14.2±11.3 0.654 
Transfer test (sec)
 §
 PRO 9.7±5.5 7.9±3.4 -10.6±21.1  
 CARB 8.4±4.5 6.7±1.7 -7.4±10.0 0.658 
Stair climb test (sec) PRO 5.6±1.1 5.4±1.6 -2.7±32.1  
 CARB 5.3±0.9 4.8±0.7 -7.6±16.4 0.703 
* % Change = change from baseline relative to baseline value [(post-intervention – baseline) / 
baseline].  
†P-value for difference in % Change between PRO and CARB groups. 
‡ Indicates significant difference between PRO and CARB at baseline, p<0.05.  
§ Indicates significant difference between baseline and post-intervention, when PRO and CARB 
groups are combined, p<0.05.  
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SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet; SEBT = star excursion balance test. 
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Table 9. Changes in lean soft tissue (LST), thigh muscle volume and indices of muscle quality 
(DXA: PRO n=13, CARB n=13; MRI: PRO n=12, CARB n=12; muscle quality: PRO n=10, 
CARB n=13) represented as mean±SD.  
 Group Baseline Post-intervention % Change* P-value† 
DXA whole body LST (kg) PRO 47.2±4.3 45.2±1.1 -4.1±4.2  
 CARB 48.1±6.2 46.9±1.6 -2.4±4.0 0.209 
DXA whole body %LST PRO 55.3±2.8 57.6±4.1 4.2±5.0  
 CARB 55.3±3.9 56.0±4.1 1.3±3.1 0.093 
DXA leg LST (kg) PRO 7.8±0.7 7.5±0.8 -3.6±3.9  
 CARB 8.1±1.1 7.9±1.1 -2.3±3.5 0.356 
DXA leg %LST PRO 52.8±4.2 55.1±3.6 4.5±4.1  
 CARB 51.8±6.4 53.1±6.6 2.4±3.0 0.138 
Whole body weight/leg LST ratio PRO 10.79±0.86 10.28±0.74 -4.6±3.6  
 CARB 10.76±0.76 10.57±0.89 -1.8±2.6 0.033 
      
MRI thigh muscle (m3) PRO 1.44±0.17 1.36±0.16 -5.0±3.4  
 CARB 1.50±0.26 1.46±0.23 -0.8±3.9 0.010 
MRI thigh muscle (% of thigh volume) PRO 37.4±6.3 40.7±6.2 10.3±8.8  
 CARB 37.0±9.0 36.8±7.1 4.5±3.4 0.049 
      
IM knee strength/body weight (Nm/kg) PRO 2.06±0.60 2.18±0.48 0.9±10.4  
 CARB 2.01±0.39 1.95±0.42 -2.7±11.9 0.462 
IM knee strength/leg %LST (Nm/%LST) PRO 3.19±0.76 3.06±0.54 -10.6±11.0  
 CARB 3.35±0.65 3.03±0.58 -8.8±12.2 0.712 
IM knee strength/muscle volume (Nm/m3) PRO 0.12±0.03 0.13±0.02 -2.7±9.6  
 CARB 0.12±0.02 0.11±0.02 -5.6±13.8 0.590 
* % Change = change from baseline relative to baseline value [(post-intervention – baseline) / 
baseline]. 
†P-value for difference in % Change between PRO and CARB groups.  
SD = standard deviation; PRO = higher protein, lower carbohydrate weight loss diet; CARB = 
higher carbohydrate, lower protein weight loss diet; DXA = dual energy X-ray absorptiometry; 
LST = lean soft tissue; whole body %LST = whole body LST/whole body mass; leg %LST = leg 
LST/leg mass; MRI =  magnetic resonance imaging; IM = isometric. 
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CHAPTER 5 
Summary and Discussion 
 
 The main findings from this study support increasing protein levels in reduced calorie 
diets to promote weight loss, and reduce fat mass while attenuating muscle loss relative to the 
weight reduction in older women. Although higher protein intake did not directly impact the 
improvements in metabolic disease profile, through enhanced fat mass loss, abdominal fat in 
particular, some improvements were detected in inflammation, which is known to impact the 
development of metabolic disease. Similarly, protein intake levels during weight loss do not 
appear to directly impact physical function. However, improvements were seen in physical 
performance as a result of weight loss and maintenance of relative lean soft tissue.  
 Interesting findings that have been recently published from the Health ABC Study link 
obesity and metabolic syndrome with incident mobility limitations (1-2). Furthermore, even after 
adjusting for whole body obesity, abdominal obesity remained independently associated with 
incident mobility limitations and elevated inflammatory markers partly explained the association 
between obesity, metabolic syndrome and mobility limitations. These Health ABC findings, 
combined with our results, suggest that there is potential for higher protein weight loss diets to 
play a key role in both reducing metabolic disease risk and functional limitations, with 
abdominal fat and inflammation being the targets for improvement. It is the intent that results 
from this small clinical trial will provide the basis for larger clinical efforts targeting the efficacy 
and effectiveness of optimal nutritional and physical activity interventions to enhance health in 
older women.  
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